National HealthCare Corporation filings document operating results, dividend actions, governance matters and capital-structure disclosures for a publicly traded senior health care company. The company’s 8-K reports include earnings releases, quarterly common dividend announcements, director appointments and other material-event disclosures, with NHC common stock registered on the NYSE American.
Proxy materials cover annual meeting matters, shareholder voting, board structure and committee governance. The filing record also describes NHC’s skilled nursing, senior living, behavioral health, home care, hospice, pharmacy, rehabilitation and third-party management activities, along with financial reporting topics such as GAAP and non-GAAP results, marketable equity securities and acquired White Oak operations.
National HealthCare Corporation announced a regular quarterly cash dividend of $0.64 per common share. The dividend will be paid to shareholders of record on March 31, 2026, with payment scheduled for April 30, 2026, reinforcing its ongoing cash return to shareholders.
As of February 1, 2026, NHC affiliates operate 80 skilled nursing facilities with 10,329 beds, 26 assisted living communities with 1,413 units, and nine independent living communities with 777 units, along with behavioral health hospitals, homecare, hospice, pharmacy, and rehabilitation services.
National Healthcare Corp (NHC) director James Paul Abernathy reported an option exercise and related share withholding. On January 15, 2026, he exercised an option granted in 2022 for 7,500 shares of common stock at a price of $69.82 per share. The company withheld 3,732 shares at $139.01 per share to pay the exercise price, resulting in net additional shares held.
Following these transactions, Abernathy beneficially owns 40,162 shares of NHC common stock, held directly. The exercised options were granted under the company’s 2020 Omnibus Equity Incentive Plan and are noted as exempt from certain short-swing profit rules. He also continues to hold option grants from 2023, 2024 and 2025, each covering 7,500 shares of common stock.
National Healthcare Corp Senior VP & General Counsel reported an equity transaction involving company stock. On 1/1/2026, a total of 1,162 shares of restricted stock that were originally granted on 3/8/2023, 3/5/2024, and 3/5/2025 vested. To cover tax obligations from this vesting, the company withheld 496 shares, recorded as a disposition at a price of $137.9 per share under transaction code F.
After this tax withholding, the insider directly beneficially owns 9,942 shares of National Healthcare Corp common stock. The filing also lists outstanding stock options giving rights to purchase additional shares in the future, all held directly by the reporting person.
National Healthcare Corp (NHC) insider equity update: A Form 4 reports that President & COO Michael Ussery had 2,063 shares of common stock withheld on 12/31/2025, coded as an "F" transaction. This reflects shares surrendered to cover tax obligations related to vesting equity awards, rather than an open-market sale. The shares were valued at $137.09 each for this tax withholding transaction, and following it, Ussery beneficially owned 158,460 shares of NHC common stock. An accompanying note explains that on 1/1/2026, a total of 4,835 restricted shares granted on 3/8/2023, 3/5/2024, and 3/5/2025 vested, with the 2,063 shares withheld by the company to satisfy tax requirements.
National Healthcare Corp executive reports share withholding for taxes and updates equity awards. A Senior VP & CIO of NATIONAL HEALTHCARE CORP (NHC) reported a Form 4 transaction dated 01/01/2026. On that date, 33 1/3% (1,070 shares) of previously granted restricted stock vested from awards originally granted on 3/8/2023, 3/5/2024, and 3/5/2025. The company withheld 403 shares, coded as an "F" transaction, at a price of $137.09 per share to cover tax obligations. Following this transaction, the officer beneficially owned 14,117.0547 shares of common stock held directly.
The filing also lists outstanding stock options held directly by the officer. These include an option to purchase 7,467 shares of common stock at $53.94 per share expiring 03/08/2028, an option to purchase 12,000 shares at $94.10 per share expiring 03/05/2029, and an option to purchase 13,500 shares at $90.62 per share expiring 02/24/2030.
National HealthCare Corp reported an insider equity update for Sr. VP Patient Services Vicki L. Dodson. On 01/01/2026, a total of 846 shares of restricted stock granted on 3/8/2023, 3/5/2024, and 3/5/2025 vested. To cover related tax obligations, the company withheld 319 shares at a price of $137.09 per share, coded as an "F" transaction (tax withholding) on the form. Following this transaction, Dodson directly beneficially owns 10,289.5455 shares of NHC common stock. She also holds stock options to purchase 3,734, 8,000, and 13,500 shares of common stock at exercise prices of $53.94, $94.10, and $90.62, expiring in 2028, 2029, and 2030, respectively.
National Healthcare Corp senior vice president and CFO reported routine equity activity. On 01/01/2026, 33 1/3% (or 1,185 shares) of previously granted restricted stock vested, and the company withheld 447 shares of common stock at $137.09 per share to cover tax obligations. Following this transaction, the officer beneficially owned 23,693 shares of common stock directly.
The filing also shows stock options held by the officer. These include options to purchase 8,000 shares of common stock at an exercise price of $53.94 exercisable from 03/08/2024 until 03/08/2028, options on another 8,000 shares at $94.10 exercisable from 03/05/2025 until 03/05/2029, and options on 13,500 shares at $90.62 exercisable from 02/24/2026 until 02/24/2030, all held directly.
National Healthcare CorpJanuary 1, 2026, 2,400 shares of restricted stock that were originally granted on March 8, 2023, March 5, 2024, and March 5, 2025 vested. To cover tax obligations, the company withheld 1,024 shares at a price of $137.09 per share, a transaction reported with code "F" for tax withholding.
After this transaction, Flatt beneficially owned 59,147 shares of common stock directly. He also holds stock options covering 6,147 shares at $53.94 exercisable until March 8, 2028, 10,000 shares at $94.10 exercisable until March 5, 2029, and 18,000 shares at $90.62 exercisable until February 28, 2030, all reported as directly owned derivative securities.
National Healthcare Corp. insider transaction: A Form 4 reports that CEO and director Stephen Flatt disposed of 450 shares of National Healthcare Corp. common stock on 12/29/2025 in a transaction coded “G” at a reported price of $0, typically indicating a gift. Following this transaction, he beneficially owns 60,171 shares of common stock directly.
The filing also lists stock options held directly by the reporting person: an option to purchase 6,147 shares at an exercise price of $53.94 exercisable from 03/08/2024 and expiring 03/08/2028; an option to purchase 10,000 shares at $94.10 exercisable from 03/05/2025 and expiring 03/05/2029; and an option to purchase 18,000 shares at $90.62 exercisable from 02/28/2026 and expiring 02/28/2030.
National Healthcare Corp (NHC) senior executive reports equity gift. The company’s SVP and CFO filed a report showing a bona fide gift of 350 shares of National Healthcare Corp common stock on 12/23/2025, recorded at a price of $0 per share, leaving 24,140 common shares beneficially owned directly after the transaction.
The filing also lists outstanding stock options held directly by the executive, including options to purchase 8,000 shares at an exercise price of $53.94 expiring on 03/08/2028, options on 8,000 shares at $94.10 expiring on 03/05/2029, and options on 13,500 shares at $90.62 expiring on 02/24/2030.